L2 immunogenic peptides of papillomavirus
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 16, 2001
Grant Date -
N/A
app pub date -
May 12, 1997
filing date -
Oct 6, 1994
priority date (Note) -
Expired
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
The N-terminal region of bovine papillomavirus (BPV-4) L2 protein includes three immunogenically active epitopes. Two of these epitopes have substantial sequence homology to human papillomavirus (HPV) types. The BPV and HPV sequences are used to produce vaccine formulations for use in cattle and humans.
Loading the Abstract Image...
OK
First Claim
Family
Loading Family data...
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully